- Display 15 Products per page
The Market for Medical Devices in EMEA: Forecasts to 2018
Published: February 11, 2014 | Price: $995.00 – $1,990.00
The Market for Medical Devices in EMEA For makers of medical devices, the European, Middle Eastern and African (EMEA) economies represent significant opportunities. This report as part of its coverage concentrates on the EMEA medical device industries and estimates the business in specific device categories. For the following countries and regions, the report contains specific device business estimates: Israel Iran UAE Jordan Saudi Arabia South Africa Egypt Europe Africa Middle East Germany France UK Italy Other Europe Highly competitive in...
The Market for Medical Devices, 12th Edition
Published: November 9, 2022 | Price: $5,000.00 – $10,000.00
The medical device industry, often referred to as the medtech industry, is an important aspect of the entire healthcare industry. The medical device industry is constantly updating and changing through the continued development of new technologies, equipment, tests and devices. Advancements in the medical device markets are life-changing and are allowing patients to live longer, healthier and more productive lives. However, the medical device industry has unique challenges. It is a heavily regulated industry in most nations of the world,...
The Market for Mobile Medical Apps
Published: June 6, 2012 | Price: $995.00 – $1,990.00
Use of mobile devices in the healthcare field has taken off in a way not surprising given the fast pace of healthcare work. Innovative companies have been well ahead of this trend and launched applications that are seeing revenues. Kalorama Information has studied the market over the past two years and found a growing market with room for new entrants. This Kalorama Information report, The Worldwide Market for Mobile Medical Apps detailsthe smartphone and other mobile applications or “apps” that are...
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)
Published: January 1, 2016 | Price: $2,396.00 – $4,792.00
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others) In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing...
The Market for Molecular Point-of-Care (mPOC), 2024
Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...
The Market for Needle-Free Drug Delivery Systems
Published: July 14, 2016 | Price: $2,800.00 – $5,600.00
The Market for Needle-Free Drug Delivery Systems The Market for Needle-Free Drug Delivery Systems, details the revenue opportunity for needle-free drug systems. The report contains seven important conclusions about the market. It also provides market estimate and forecast for jet technology and market estimate and forecast for other needle-free technology, as well as estimates and forecasts of the insulin, vaccine, pediatric, and pain needle-free delivery market segments. Becton Dickinson, Antares Pharma, Inc., Akra D ermojet, and 3M Pharmaceuticals are among...
The Market for Next-Generation Sequencing and Kalorama Survey of NGS Laboratories
Published: August 2, 2019 | Price: $6,000.00 – $12,000.00
Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023...
The Market for Personalized Gene Therapy Treatments for Cancer: Forecasts to 2025
Published: December 23, 2014 | Price: $995.00 – $1,990.00
In the past, cancer treatments could be painful, invasive and damage the patient's body. Now there are many novel techniques available for cancer patients that are not as invasive and detrimental to the body as a whole. Gene therapy is the most prominent new form of these alternative treatments. This report, The Market for Personalized Gene Therapy Treatments For Cancer provides a complete review of the market potential for relatively new approach in cancer research, that of changing...
The Market for Prenatal, Newborn and Carrier Genetic Testing: Forecasts to 2019
Published: May 1, 2015 | Price: $1,995.00 – $3,995.00
The Market for Prenatal, Newborn and Carrier Genetic Testing The Market for Prenatal, Newborn and Carrier Genetic Testing discusses the technologies and tests used in chromosomal analysis and in the diagnosis of inherited disorders and the detection of carriers of inherited diseases. The growing global genetic testing laboratory services market is discussed, including: carrier testing prenatal testing newborn screening neonatal/pediatric testing testing for adult onset genetic disorders The growing number of genetic tests has been made possible by advances in...
The Market for RNA Sequencing
Published: August 24, 2020 | Price: $5,500.00 – $11,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
The Market for RNA Sequencing, 2nd Edition
Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
The Market for RNA Sequencing, 3rd Edition
Published: September 8, 2023 | Price: $5,000.00 – $10,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
The Market for Rx to OTC Switches, 5th Edition
Published: February 1, 2011 | Price: $150.00 – $300.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where possible. In the early part of the last decade there was a decline in Rx-to-OTC switches; since 2006, however, there has been a number of uses of this tactic to extend the revenue of pharmaceutical products. In Kalorama Information's Market for...
The Market for Rx-to-OTC Switches, 8th Edition
Published: May 5, 2022 | Price: $6,000.00 – $12,000.00
More than 700 pharmaceutical products have made the switch from Rx to OTC over the past several decades. The U.S. Rx-to-OTC market has grown into a $13.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective...
The Market for Sample Preparation for Next Generation Sequencing (NGS)
Published: April 27, 2016 | Price: $3,360.00 – $6,720.00
The Market for Sample Preparation for Next Generation Sequencing (NGS) The Market for Sample Preparation for Next Generation Sequencing (NGS) covers trends, challenges, strategies, manufacturers, and products, and provides estimates of revenue share and market growth, which includes NGS hardware and consumables. Data presented include NGS sample preparation market and growth rate, 2015-2020; market by geographic region, 2015 (North America, Europe, Asia-Pacific, rest-of-world); market by product type, 2015 (enrichment, libr prep kits panels, etc.; automation/ hardware; nucleic acid extraction; total);...